lower doses
FDA Clears BioNTech-MediLink ADC Trial to Resume with Reduced Doses
BioNTech, MediLink, ADC trial, FDA approval, lower doses, cancer treatment, HER3, patient safety
Actionable Insights Powered by AI
BioNTech, MediLink, ADC trial, FDA approval, lower doses, cancer treatment, HER3, patient safety